Graph Attention Network-Based Prediction of Drug-Gene Interactions of Signal Transducer and Activator of

Shubhangini Chatterjee1, Pradeep Kumar Yadalam1

  • 1Department of Periodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

Cureus
|October 8, 2024
PubMed

Insights

This study explored predicting drug-gene interactions for STAT-1 in periodontal inflammation using graph attention networks (GATs). The model showed low accuracy due to data limitations and complexity.

Area of Science:

  • Biomedical Informatics
  • Computational Biology
  • Genomics

Background:

  • Signal transducer and activator of transcription-1 (STAT-1) pathways are crucial in cellular signaling and gene regulation.
  • Aberrant STAT activation, particularly STAT-3 and STAT-5, is implicated in various human tumors.
  • STAT-1 dysfunction is linked to conditions like periodontitis, a chronic inflammatory gum disease.

Purpose of the Study:

  • To predict drug-gene interactions involving STAT-1 receptors in the context of periodontal inflammation.
  • To apply graph attention networks (GATs) for modeling these complex biological interactions.
  • To investigate the potential of computational approaches for understanding STAT-1 related diseases.

Main Methods:

  • A dataset of 215 drug-gene interactions was utilized for training and testing a GAT model.
  • Data preprocessing involved cleaning and normalization before GAT application.
  • Network visualization and analysis were performed using Cytoscape and cytoHubba.

Main Results:

  • The drug-gene interactome network comprised 657 nodes and 1591 edges.
  • The predictive GAT model demonstrated low accuracy in predicting drug-gene interactions.
  • Challenges included data availability, model complexity, and feature representation.

Conclusions:

  • The GAT model's low accuracy highlights limitations in current data and methodologies for predicting STAT-1 drug-gene interactions in periodontal inflammation.
  • Further research with more comprehensive datasets and advanced modeling techniques is warranted.
  • Understanding these interactions is critical for developing targeted therapies for inflammatory diseases.

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.0K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K